Johnson & Johnson Investor Presentation — October 2021

Document content

October 19, 2021Cautionary Note on Forward -looking Statements

3This presentation contains “forward -looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regar ding, among other things: future

operating and financial performance, product development, market position and business strategy. The reader is cautioned not to rely on these forward -looking

statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate o r known or unknown risks or

uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. R isks and uncertainties include, but are not

limited to: risks related to the impact of the COVID -19 global pandemic, such as the scope and duration of the outbreak, governm ent actions and restrictive measures

implemented in response, material delays and cancellations of medical procedures, supply chain disruptions and other impacts to the business, or on the Company’s

ability to execute business continuity plans, as a result of the COVID -19 pandemic; economic factors, such as interest rate and currency exchange rate fluctuations;

competition, including technological advances, new products and patents attained by competitors; challenges inherent in new p roduct research and development,

including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and e xisting products; challenges to patents; the

impact of patent expirations; the ability of the Company to successfully execute strategic plans; the impact of business comb inations and divestitures; manufacturing

difficulties or delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recal ls or regulatory action; significant adverse litigation